Every Stock
Consumer ServicesLooking to sell Every stock or options?
Every produces food products and probiotic beverages designed to provide animal-free proteins. Their offerings include nutritional supplements that can be added to food and beverages for a protein boost. These products contain no added sugar and offer a healthy, sustainable, and affordable protein option for consumers seeking animal-free protein choices.
Temasek Holdings, Main Sequence Ventures, OurCrowd, McWin Capital Partners, Veronorte, Atom Expeditions, Rich Products Ventures, Valante Capital, QC VENTURES, The Production Board, Brkfst Club, Mission and Market, Northstar.VC, SeedFord Partners, Essential Capital (New York), Good Startup, Anne Hathaway, Agronomics, Starlight Ventures, Beyond Impact, Scott Banister, Stefano Bernardi, IOVC, CPT Capital, Losa Group.
Collective explained in 2 minutes
Learn how Collective's solutions enable you to manage your risk and maximize your wealth
Our available services for this company
Management Team
Board Members
Every’s stock FAQs
Every is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Every stock. Depending on Every’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Every stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Every stock in two ways. First, Every employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Every stock. Note that all transactions in Every shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Every stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Every stock. Typically, shares of private companies like Every are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Dec 2021, Every is reported to have closed an equity financing in which the investors valued the company at $586M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Every shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Every is not currently publicly traded, it does not have a ticker symbol.
Every has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Every is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Every shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.
